Bank of America
ABVX

Bank of America’s Abivax ABVX Stock Holding History

Bank of America’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.9M Buy
735,729
+213,440
+41% +$25.3M 0.01% 1264
2025
Q4 		$70.4M Buy
522,289
+426,696
+446% +$46.6M 0.01% 1323
2025
Q3 		$8.12M Buy
95,593
+95,057
+17,735% +$5.83M ﹤0.01% 3508
2025
Q2 		$4.1K Sell
536
-10,170
-95% -$66.3K ﹤0.01% 7329
2025
Q1 		$66.9K Buy
10,706
+5,170
+93% +$35K ﹤0.01% 6656
2024
Q4 		$40.5K Buy
5,536
+1,990
+56% +$18.3K ﹤0.01% 6687
2024
Q3 		$40.8K Buy
3,546
+727
+26% +$8.71K ﹤0.01% 6600
2024
Q2 		$37.3K Buy
2,819
+547
+24% +$7.82K ﹤0.01% 6589
2024
Q1 		$32.5K Buy
+2,272
New +$29.3K ﹤0.01% 6639

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Bank of America's ABVX Position: Q1 2026 in Review

Bank of America increased its Abivax (ABVX) stake by 41% in Q1 2026, buying an estimated $25.3M and bringing the position to 735,729 shares worth $81.9M. The position accounts for 0.01% of the portfolio, ranked #1264.

Bank of America first reported a position in ABVX in Q1 2024 and has held it in 9 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Bank of America held 735,729 shares of Abivax worth $81.9M as of Q1 2026.
  • Bank of America bought 213,440 Abivax shares in Q1 2026, an estimated $25.3M.
  • Abivax made up 0.01% of Bank of America's portfolio in Q1 2026, its #1264 holding.
  • Bank of America first reported a position in Abivax in Q1 2024 and has held it in 9 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.